Table 2 The association between coffee intake by the number of cups per day and digestive cancer within the UK Biobank

From: Coffee consumption by type and risk of digestive cancer: a large prospective cohort study

   

Coffee intake (cups/day)

HR per cup increase

p-trend

 

0

Any

>0–2

3–4

≥5

n

104,465

365,157

215,739

97,022

52,396

Oesophageal cancer

 Cases

74

279

146

72

61

  

 Unadjusted HR

1.00

0.97 (0.75, 1.25)

0.84 (0.63, 1.11)

0.93 (0.67, 1.29)

1.60 (1.14, 2.24)

1.07 (1.03, 1.10)

<0.001

 Adjusted HR

1.00

1.15 (0.83, 1.61)

1.11 (0.77, 1.58)

1.08 (0.71, 1.65)

1.47 (0.94, 2.30)

1.03 (0.98, 1.07)

0.28

Oesophageal squamous cell carcinoma

 Cases

15

61

28

15

18

  

 Unadjusted HR

1.00

1.05 (0.60, 1.86)

0.80 (0.42, 1.51)

0.97 (0.47, 1.99)

2.34 (1.18, 4.64)

1.09 (1.03, 1.15)

0.001

 Adjusted HR

1.00

1.26 (0.59, 2.67)

0.94 (0.41, 2.14)

1.10 (0.42, 2.87)

2.88 (1.20, 6.92)

1.08 (1.02, 1.16)

0.01

Oesophageal adenocarcinoma

 Cases

55

204

110

52

42

  

 Unadjusted HR

1.00

0.94 (0.70, 1.27)

0.84 (0.61, 1.17)

0.90 (0.61, 1.32)

1.47 (0.98, 2.20)

1.06 (1.01, 1.11)

0.008

 Adjusted HR

1.00

1.21 (0.81, 1.80)

1.25 (0.83, 1.89)

1.07 (0.65, 1.76)

1.25 (0.72, 2.15)

1.00 (0.93, 1.07)

0.96

Gastric cancer

 Cases

65

184

99

55

30

  

 Unadjusted HR

1.00

0.72 (0.55, 0.96)

0.65 (0.47, 0.88)

0.81 (0.56, 1.16)

0.90 (0.58, 1.39)

1.00 (0.95, 1.07)

0.79

 Adjusted HR

1.00

0.98 (0.68, 1.41)

0.88 (0.59, 1.30)

1.14 (0.73, 1.79)

1.18 (0.70, 1.98)

1.03 (0.97, 1.09)

0.30

Small intestinal cancer

 Cases

14

63

31

20

12

  

 Unadjusted HR

1.00

1.18 (0.66, 2.11)

0.97 (0.51, 1.82)

1.40 (0.71, 2.78)

1.68 (0.78, 3.64)

1.05 (0.96, 1.14)

0.27

 Adjusted HR

1.00

1.39 (0.60, 2.87)

1.12 (0.49, 2.58)

1.67 (0.67, 4.18)

1.65 (0.56, 4.78)

1.02 (0.90, 1.17)

0.65

Colon cancer

 Cases

320

1141

666

340

135

  

 Unadjusted HR

1.00

0.93 (0.82, 1.05)

0.90 (0.79, 1.03)

1.04 (0.89, 1.21)

0.82 (0.67, 1.00)

0.98 (0.95, 1.00)

0.16

 Adjusted HR

1.00

0.91 (0.78, 1.05)

0.89 (0.76, 1.05)

0.97 (0.80, 1.18)

0.87 (0.68, 1.11)

0.97 (0.93, 1.01)

0.15

Rectal and anal cancer

 Cases

176

610

361

155

94

  

 Unadjusted HR

1.00

0.91 (0.77, 1.08)

0.90 (0.76, 1.08)

0.87 (0.70, 1.08)

1.04 (0.81, 1.33)

1.01 (0.98, 1.04)

0.37

 Adjusted HR

1.00

0.88 (0.72, 1.08)

0.90 (0.72, 1.11)

0.81 (0.62, 1.06)

0.95 (0.70, 1.30)

1.00 (0.96, 1.04)

0.90

Liver cancer

 Cases

48

134

82

32

20

  

 Unadjusted HR

1.00

0.72 (0.52, 1.00)

0.74 (0.52, 1.05)

0.65 (0.41, 1.01)

0.81 (0.48, 1.37)

0.96 (0.89, 1.04)

0.34

 Adjusted HR

1.00

0.87 (0.58, 1.30)

0.88 (0.57, 1.36)

0.87 (0.51, 1.48)

0.83 (0.45, 1.55)

0.97 (0.89, 1.05)

0.44

Hepatocellular carcinoma

 Cases

26

62

39

14

9

  

 Unadjusted HR

1.00

0.61 (0.39, 0.97)

0.64 (0.39, 1.05)

0.52 (0.27, 1.00)

0.68 (0.32, 1.45)

0.93 (0.82, 1.04)

0.22

 Adjusted HR

1.00

0.50 (0.29, 0.87)

0.55 (0.30, 1.00)

0.44 (0.20, 0.96)

0.44(0.17, 1.12)

0.87 (0.76, 1.01)

0.07

Intrahepatic bile duct carcinoma

 Cases

16

56

36

14

6

  

 Unadjusted HR

1.00

0.90 (0.52, 1.57)

0.97 (0.53, 1.74)

0.84 (0.41, 1.73)

0.72 (0.28, 1.85)

0.95 (0.84, 1.07)

0.43

 Adjusted HR

1.00

1.49 (0.71, 3.11)

1.47 (0.68, 3.18)

1.80 (0.74, 4.34)

1.06 (0.32, 3.48)

1.00 (0.88, 1.14)

0.90

Gallbladder and extrahepatic bile duct carcinoma

 Cases

14

81

47

20

14

  

 Unadjusted HR

1.00

1.48 (0.84, 2.61)

1.43 (0.78, 2.59)

1.37 (0.69, 2.71)

1.93 (0.92, 4.06)

1.05 (0.96, 1.13)

0.23

 Adjusted HR

1.00

1.63 (0.81, 3.27)

1.52 (0.74, 3.15)

1.56 (0.67, 3.64)

2.40 (0.98, 5.90)

1.06 (0.97, 1.15)

0.15

Pancreatic cancer

 Cases

81

303

171

83

49

  

 Unadjusted HR

1.00

0.95 (0.75, 1.22)

0.89 (0.68, 1.16)

0.98 (0.72, 1.33)

1.17 (0.82, 1.67)

1.03 (0.98, 1.07)

0.17

 Adjusted HR

1.00

0.89 (0.66, 1.20)

0.86 (0.63, 1.18)

0.88 (0.60, 1.28)

1.08 (0.71, 1.65)

1.02 (0.97, 1.06)

0.44

All digestive cancers

 Cases

784

2767

1,581

773

413

  

 Unadjusted HR

1.00

0.91 (0.84, 0.99)

0.87 (0.80, 0.95)

0.96 (0.87, 1.06)

1.02 (0.91, 1.15)

1.01 (0.99, 1.02)

0.17

 Adjusted HR

1.00

0.95 (0.86, 1.05)

0.92 (0.83, 1.02)

0.98 (0.87, 1.11)

1.05 (0.90, 1.21)

1.00 (0.98, 1.02)

0.53

  1. The model contains age at baseline, sex, deprivation, education, BMI, alcohol, smoking, fruit and vegetable intake, tea intake, physical activity and comorbidities at baseline (including high cholesterol, hypertension, diabetes, angina, myocardial infarction, stroke, peptic ulcer disease, hepatitis, cirrhosis and gallstones)